Select Medical Holdings Corporation

Informe acción NYSE:SEM

Capitalización de mercado: US$3.5b

Select Medical Holdings Crecimiento futuro

Future controles de criterios 1/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Select Medical Holdings de 14% y 4.4% por año respectivamente. Se prevé que el BPA crezca en un 8.3% al año. Se espera que la rentabilidad financiera sea de 15.7% en 3 años.

Información clave

14.0%

Tasa de crecimiento de los beneficios

8.3%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare16.0%
Tasa de crecimiento de los ingresos4.4%
Rentabilidad financiera futura15.7%
Cobertura de analistas

Low

Última actualización12 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Apr 19
Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Apr 11
Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Select Medical: Solid Growth Prospects And A Compelling Valuation

Mar 05

Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

Feb 18
Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt

Jan 15
We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt

Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes

Dec 31
Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes

Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Nov 06
Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors

Oct 25

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Oct 04
What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?

Sep 16
Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?

Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold

Aug 11

Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125

Aug 07
Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125

Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

Jul 14
Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?

Jun 29
At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

May 27
Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

Select Medical: Revising To Hold As Business Economics Roll Lower

May 26

Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital

Apr 05
Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital

Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?

Mar 17
Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?

Select Medical GAAP EPS of $0.22 misses by $0.11, revenue of $1.58B in-line

Feb 23

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

Jan 31
Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence

Dec 20
The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence

Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?

Dec 01
Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?

Select Medical declares $0.125 dividend

Nov 03

These 4 Measures Indicate That Select Medical Holdings (NYSE:SEM) Is Using Debt Extensively

Nov 01
These 4 Measures Indicate That Select Medical Holdings (NYSE:SEM) Is Using Debt Extensively

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Sep 16
Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Select Medical: Adding To Position For Further Upside Capture

Sep 14

Calculating The Fair Value Of Select Medical Holdings Corporation (NYSE:SEM)

Aug 31
Calculating The Fair Value Of Select Medical Holdings Corporation (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Aug 10
Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Select Medical down 9% on Q2 profit miss, reiterates full-year forecast

Aug 05

Select Medical Holdings (NYSE:SEM) Has A Somewhat Strained Balance Sheet

Jul 31
Select Medical Holdings (NYSE:SEM) Has A Somewhat Strained Balance Sheet

Select Medical: Return Objective Of 26% Justifies Fit In Equity Portfolios

Jul 01

Is Now The Time To Put Select Medical Holdings (NYSE:SEM) On Your Watchlist?

Jun 05
Is Now The Time To Put Select Medical Holdings (NYSE:SEM) On Your Watchlist?

At US$24.30, Is It Time To Put Select Medical Holdings Corporation (NYSE:SEM) On Your Watch List?

May 22
At US$24.30, Is It Time To Put Select Medical Holdings Corporation (NYSE:SEM) On Your Watch List?

Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of US$0.13

May 09
Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of US$0.13

Previsiones de crecimiento de beneficios e ingresos

NYSE:SEM - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20267,622335N/AN/A2
12/31/20257,287407N/AN/A5
12/31/20246,968361N/AN/A5
12/31/20236,664235353582N/A
9/30/20236,587217191415N/A
6/30/20236,489196177393N/A
3/31/20236,399174128330N/A
12/31/20226,33415394285N/A
9/30/20226,31217521212N/A
6/30/20226,27822319216N/A
3/31/20226,258329-20168N/A
12/31/20216,205389221401N/A
9/30/20216,105415503669N/A
6/30/20215,995415553705N/A
3/31/20215,6643061,0771,224N/A
12/31/20205,5322508821,028N/A
9/30/20205,446206860999N/A
6/30/20205,415162859998N/A
3/31/20205,544155300448N/A
12/31/20195,454143288445N/A
9/30/20195,344136210380N/A
6/30/20195,218138235410N/A
3/31/20195,153140308485N/A
12/31/20185,081133327494N/A
9/30/20184,911207309489N/A
6/30/20184,720193205415N/A
3/31/20184,527189123345N/A
12/31/20174,3651715238N/A
9/30/20174,30093N/A196N/A
6/30/20174,25982N/A209N/A
3/31/20174,23774N/A180N/A
12/31/20164,217112N/A347N/A
9/30/20164,211121N/A286N/A
6/30/20164,178143N/A312N/A
3/31/20163,973146N/A282N/A
12/31/20153,683127N/A208N/A
9/30/20153,420123N/A222N/A
6/30/20153,165121N/A204N/A
3/31/20153,052119N/A224N/A
12/31/20143,020117N/A171N/A
9/30/20142,997121N/A230N/A
6/30/20142,963118N/A213N/A
3/31/20142,949111N/A188N/A
12/31/20132,938112N/A193N/A
9/30/20132,936122N/A220N/A
6/30/20132,925123N/A202N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (14% al año) de SEM es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (14% al año) de SEM crezcan menos que el mercado US (14.4% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de SEM crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (4.4% al año) de SEM crezcan más despacio que el mercado de US (7.9% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 4.4% al año) de SEM crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de SEM sea baja dentro de 3 años (15.7%).


Descubre empresas en crecimiento

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target